Breast cancer treatment – the next advances
February 7, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab
When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …
Merck prepares insomnia candidate
February 7, 2012Sales and Marketing Merck, insomnia
Merck is to file its new insomnia drug suvorexant, with US regulators later this year. Suvorexant is an orexin receptor …
Dr Stephen Rosevear joins Cogent as director of Research & Policy
February 7, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear
Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …
Roche rounds off year with solid performance
February 3, 2012Sales and Marketing Roche
A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results …
Andrew Morgan joins Republic M!
February 2, 2012Business Services, Medical Communications, Sales and Marketing Andrew Morgan, Republic M!
Republic M! has strengthened its team with the appointment of Andrew Morgan as head of operations. Andrew has leadership expertise …
Merck posts strong results for 2011
February 2, 2012Sales and Marketing Frazier, Merck, Singulair, Victrelis
Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011. The US firm …
Working Life: Carlos Gallardo, general manager, Almirall
February 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo
BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …
AstraZeneca to cut 7,300 jobs as growth stalls
February 2, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D
AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …
Pfizer recalls oral contraceptive for packaging errors
February 2, 2012Manufacturing and Production Akrimax, Bedford, Cephalon, Lo/Ovral-28, Pfizer, Teva
Pfizer has been forced to recall a large volume of oral contraceptive packs distributed in the US market because a …
Zytiga cost too high, says NICE
February 2, 2012Sales and Marketing NICE, Zytiga
NICE is not recommending Janssen’s prostate cancer pill Zytiga because of its high cost. Zytiga (abiraterone) is not recommended, in …
RSA announces promotions
February 2, 2012Medical Communications, Sales and Marketing rsa
Life sciences executive search and interim management specialist firm RSA, has announced its latest promotions.John Callagher (pictured) has been promoted …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
